Literature DB >> 3018791

Differential effects of amphetamine and related compounds on locomotor activity and metabolic rate in mice.

P J Bushnell.   

Abstract

Locomotor activity was measured by photobeam interruptions, and metabolic rate by the production of CO2 (as minute volume expired CO2, or VECO2) in mice. d-Amphetamine (0.3 to 10 mg/kg IP) increased locomotor activity in a dose-dependent manner while suppressing VECO2 over the same 72-min test period, compared to saline-injected controls. This phenomenon of divergent effects on locomotor activity and metabolic rate required central stimulation, as neither ammonium sulfate nor p-hydroxyamphetamine suppressed VECO2. Oxygen consumption was also suppressed by d-amphetamine, indicating that the suppression of VECO2 involved more than a change in respiratory quotient. When baseline activity rates were increased with running wheels, VECO2 and activity were both suppressed by d-amphetamine; VECO2 was suppressed by d-amphetamine more in exercising mice than in sedentary mice. Anorexigenic agents phenmetrazine, aminoxaphen, and fenfluramine, when administered in doses equimolar to maximally effective doses of d-amphetamine, did not consistently affect activity or VECO2. Evidence for mediation of the VECO2 response by corticosterone and endogenous opioid peptides was negative. Further work, with other mediators of the stress response, or with more complete dose-effect studies with anorexigenic compounds, may be necessary to explicate the mechanism of this counter-intuitive divergence of two measures of activity in mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018791     DOI: 10.1016/0091-3057(86)90248-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Locomotor responses to benzodiazepines, barbiturates and ethanol in diazepam-sensitive (DS) and -resistant (DR) mice.

Authors:  T J Phillips; E J Gallaher
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems.

Authors:  Hiroshi Onogi; Masato Hozumi; Osamu Nakagawasai; Yuichiro Arai; Seiichiro Ishigaki; Atsushi Sato; Seiichi Furuta; Fukie Niijima; Koichi Tan-No; Takeshi Tadano
Journal:  Psychopharmacology (Berl)       Date:  2009-12-04       Impact factor: 4.530

3.  Evidence for monoaminergic involvement in triadimefon-induced hyperactivity.

Authors:  K M Crofton; V M Boncek; R C MacPhail
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.

Authors:  D B Miller; J P O'Callaghan
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

5.  Food consumption and weight gain after cessation of chronic amphetamine administration.

Authors:  Caitlin A Orsini; Guy Ginton; Kristy G Shimp; Nicole M Avena; Mark S Gold; Barry Setlow
Journal:  Appetite       Date:  2014-03-22       Impact factor: 3.868

6.  Elevated body fat increases amphetamine accumulation in brain: evidence from genetic and diet-induced forms of adiposity.

Authors:  Xiuping Fu; Aparna P Shah; Jacqueline Keighron; Ta-Chung M Mou; Bruce Ladenheim; Jesse Alt; Daisuke Fukudome; Minae Niwa; Kellie L Tamashiro; Gianluigi Tanda; Akira Sawa; Jean-Lud Cadet; Rana Rais; Jay M Baraban
Journal:  Transl Psychiatry       Date:  2021-08-14       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.